发明申请
US20130310405A1 SUBSTITUTED PYRIMIDO[1,2-B]INDAZOLES AND THEIR USE AS MODULATORS OF THE PI3K/AKT PATHWAY
有权
取代的PYRIMIDO [1,2-B]吲哚并作为PI3K / AKT途径的调节剂使用
![SUBSTITUTED PYRIMIDO[1,2-B]INDAZOLES AND THEIR USE AS MODULATORS OF THE PI3K/AKT PATHWAY](/docs/US/2013-11-21/US20130310405A1/abs.jpg.600x600.jpg)
- 专利标题： SUBSTITUTED PYRIMIDO[1,2-B]INDAZOLES AND THEIR USE AS MODULATORS OF THE PI3K/AKT PATHWAY
- 专利标题（中）： 取代的PYRIMIDO [1,2-B]吲哚并作为PI3K / AKT途径的调节剂使用
-
申请号： US13994517申请日： 2011-12-13
-
公开(公告)号： US20130310405A1公开(公告)日： 2013-11-21
- 发明人: Hartmut Rehwinkel , Andrea Hägebarth , Oliver Politz , Roland Neuhaus , Ulf Bömer
- 申请人： Hartmut Rehwinkel , Andrea Hägebarth , Oliver Politz , Roland Neuhaus , Ulf Bömer
- 申请人地址： DE Monheim
- 专利权人： BAYER INTELLECTUAL PROPERTY GMBH
- 当前专利权人： BAYER INTELLECTUAL PROPERTY GMBH
- 当前专利权人地址： DE Monheim
- 优先权： EP10195397.4 20101216
- 国际申请： PCT/EP2011/072593 WO 20111213
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K45/06 ; A61K31/519
![SUBSTITUTED PYRIMIDO[1,2-B]INDAZOLES AND THEIR USE AS MODULATORS OF THE PI3K/AKT PATHWAY](/abs-image/US/2013/11/21/US20130310405A1/abs.jpg.150x150.jpg)
摘要：
Compounds of Formula (I), which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals. The compounds of formula (I) a: useful for the treatment of cancer.
公开/授权文献
信息查询
